GAM501

BIOLOGICAL2 trials

Sponsors

Tissue Repair Company

Conditions

DiabetesDiabetic FootDiabetic Foot UlcersFoot WoundsWounds and Injuries

Phase 1

Gene Therapy to Improve Wound Healing in Patients With Diabetes

CompletedNCT00065663

Tissue Repair CompanyDiabetes, Diabetic Foot Ulcers, Foot Wounds +1

Start: 2002-08-31End: 2004-12-31Target: 21Updated: 2007-11-20

Phase 2

Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities

CompletedNCT00493051

Tissue Repair CompanyDiabetic Foot

Start: 2007-11-30End: 2009-12-31Updated: 2010-02-10